表紙
市場調查報告書

全球生物印刷市場分析與預測:2018年∼2025年

Global Bioprinting Market: Focus on Product, Application, Technology, Country Analysis, Patent Analysis, Market Share, and Competitive Landscape - Analysis and Forecast 2018-2025

出版商 BIS Research Inc. 商品編碼 650363
出版日期 內容資訊 英文 274 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球生物印刷市場分析與預測:2018年∼2025年 Global Bioprinting Market: Focus on Product, Application, Technology, Country Analysis, Patent Analysis, Market Share, and Competitive Landscape - Analysis and Forecast 2018-2025
出版日期: 2018年06月08日內容資訊: 英文 274 Pages
簡介

本報告提供全球生物印刷市場相關調查分析,市場概要,市場動態,競爭情形,各產品、應用、技術、地區的市場分析與預測,主要企業簡介等系統性資訊。

摘要整理

第1章 市場概要

  • 簡介
  • 市場趨勢
  • 生物印刷的歷史性的發展
  • 內臟器官製做用各種生物印刷技術比較
  • 生物印刷的進步
  • 生物印刷的階段

第2章 市場動態

  • 概要
  • 市場成長的促進要素、抑制因素的影響分析
  • 推動市場要素
  • 阻礙市場要素
  • 市場機會

第3章 競爭考察

  • 主要市場發展與策略
  • 產業的魅力
  • 市場佔有率分析

第4章 產業分析

  • 專利形勢
  • 聯盟,協會,及法規團體
  • 法律上的必要條件、規定

第5章 全球生物印刷市場:各產品

  • 概要
  • 生物印表機
  • 軟體
  • 消耗品
  • 服務
  • 其他

第6章 全球生物印刷市場:各應用領域

  • 概要
  • 調查應用
    • 培養3D細胞
    • 再生醫療
    • 醫藥品研究
    • 其他
  • 臨床應用
    • 牙科
    • 整形外科
    • 皮膚替代品、移植皮膚片
    • 維管束組織、內臟器官
  • 其他

第7章 全球生物印刷市場:各技術

  • 概要
  • 噴墨型技術
  • 擠壓型技術
  • 磁漂浮
  • 光硬化技術
  • 其他

第8章 全球生物印刷市場:各地區

  • 市場概要
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 其他 (RoW)

第9章 企業簡介

  • Advanced Solutions (Life Sciences)
  • Allevi (BioBots)
  • Aspect Biosystems Ltd.
  • Autodesk
  • Cellink
  • Digilab Inc.
  • 3Dynamics Systems Ltd.
  • EnvisionTEC
  • nScrypt Inc.
  • Organovo Holdings, Inc.
  • Poietis
  • RegenHU Ltd.
  • Regenovo Biotechnology Co., Ltd
  • SunP Biotech llc
  • Vivax Bio llc
  • Ather
  • Biolife4D
  • Cellenion
  • Cyfuse Biomedical K.K.
  • GeSIM
  • Materialize NV
  • Regemat3D
  • Rokit
  • Sichuan Revotek Co. Ltd.
  • SE3D
  • Stratasys

第10章 附錄

目錄
Product Code: BH060A

3D printing has emerged significantly with broader applications areas especially in the healthcare sector. 3D printed customized medical devices, such as hearing aids, dental implants and prosthetics, have become quite successful. Bioprinting which is a subset of 3D printing works on the same principal of 3D printing except the procedure is performed using living cells, tissues, and organs, where the complexities of tissues and cells, such as cell types, functionalities, growth, and differentiation patterns, are addressed. It is the artificial construction of living tissues through placing layer upon layer of living cells. It is a variant of biomedical application of rapid prototyping technology or layer by layer additive bio-fabrication of 3D tissue and organ constructs for the replacement, repair, and regeneration of damaged and diseased human organs and tissues. Although, bioprinters come in various configurations, the basic process is the same. All machines extract an adequate number of cells, which comes from a bio print head in order to build up a three-dimensional organic object. Most of the bioprinters extract a dissolvable gel (as a scaffold) to protect and support cells during printing.

The advent of 3D bioprinting technologies has led to significant progress in the manufacturing of large bioartificial organs, such as bones, livers, hearts, cartilages, and skins. It can produce living tissues, blood vessels, and potentially whole organs for its usage in medical procedures, drug discovery & testing, tissue engineering research & study, and others. The advantages of 3D bioprinting over other fabrication techniques are: it enables fabrication of anatomically correct shapes, allows fabrication of porous structures, can co -culture multiple cell types locally, and control the delivery of growth factors and genes, as well as can generate tissue models in high-throughput manner and integrate vascularization.

The widening gap between the demand and the supply of organ transplants represent a huge unmet need amongst the patients and doctors. The emerging bioprinting technologies has a strong potential in filling this gap. The eventual goal of researchers is to be able to produce bio printed organs for organ implants. The market is expected to progress gradually over the coming years with the focus of shifting from research to commercialization. The early success of the bio-printed organ transplants is likely to provide additional boost in the subsequent years.

This research study includes an extensive analysis of the global bioprinting market by product, application, technology and geographical region, allowing the researcher to develop a comprehensive outlook of the market. Each of these segments has been analyzed based on their current and future market size, considering the macro and micro environmental factors.

The market report presents a detailed and investigative study of the entire market and provides a comprehensive insight into various forms of development, trends, and the key market participants. While highlighting the key driving and restraining forces for this dynamic market, the report also provides a comprehensive section on competitive landscape, market share analysis, competitive benchmarking, and the position of the competitors within the global bioprinting market.

The following key questions have been addressed in the report:

  • What are the major market drivers, challenges, and opportunities of the global bioprinting market?
  • How did the advanced bioprinting technologies evolve and what is its scope in the future?
  • What were the market shares of the leading segments and sub-segments of the global bioprinting market in 2016 and what will be its shares in 2025?
  • How will each of the segments of the global bioprinting market grow during the forecast period and what will be the revenue generated by each of the segments by the end of 2025?
  • How did the market share of the leading companies change in 2016, and which country will lead the market in 2017?
  • How will the bioprinting industry evolve during the forecast period 2018-2025?
  • What are the key developments and strategies implemented by the key players to stand out in this market?
  • Which product, application and technology will dominate the global bioprinting market by the end of the forecast period, and which one is growing at the highest CAGR during the forecast period 2018-2025?
  • What will be the growth rate of different segments during the forecast period? Which is the leading segment by product, application, technology and region?
  • Who are the key players in the global bioprinting market?
  • Which region will lead the global bioprinting market in revenue generation through the forecast period?
  • Which country will be growing at the highest CAGR during the forecast period?

The key players who have significant contributions to the bioprinting market are Organovo Holdings Inc., Aspect Biosystems, Advanced Solutions Inc. (Life Sciences), Allevi (BioBots), 3Dynamics Systems, Cellink, Cyfuse Biomedical K.K., RegenHU, Regenovo Biotechnology Co. Ltd., and Poietis, among others.

Executive Summary

The 3D printing market has continuously evolved in the past three years, proving to be one of the most promising industries to look up to in terms of investment. Suitable for today's technological and commercial areas, the 3D is the process used to produce three-dimensional objects.

3D printing is a well-known concept having advanced ability to use digital instructions (software guidance) to manufacture specific shapes using ceramics, plastics, polymers, metal alloys, and other materials. The 3D printing industry has experienced a rapid growth rate in the past few years due to its diverse applications. Active support of government and industry players in increasing the awareness regarding the benefits of using 3D printing over conventional methods of manufacturing serves as a strong factor attributed to the growth of the global 3D printing market. Moreover, the ongoing technological advancements, such as incorporation of new materials and surface enhancement of the final model, ease in the development of customized products, reduction in manufacturing cost, and government investments in 3D printing projects are some of the other favorable factors for the growth of the 3D printing market.

With the advancement in modern science and technology, organ failure or deterioration caused by the acute/chronic diseases, congenita malformations, and traffic accidents have become the most prominent social problems. As per the Journal of Chinese Medical Ethics, there are around 1.5 million patients who require organ transplantations in China every year, but only less than 1% of patients can obtain suitable organs. As compared to the traditional artificial organs made up of polymers or metals, the bioartificial organs are made up of living cells and biomaterials. A wide variety bioprinting strategies have been developed to tackle the challenges for the manufacturing of bioartificial organs with physiological functions. The objective of these strategies is to build complex organ geometries through a spatiotemporal pattern of heterogenous types of bio-inks, especially cells.

Developments in 3D bioprinting technologies have made possible printing of bioartificial organs, such as heart, liver, bones, cartilages, and skin. Using 3D bioprinting technologies in living tissues, blood vessels and whole organs can be developed for use in medical procedures, drug discovery & drug trials, tissue engineering research and other medical and biomedical applications. Advantages of 3D bioprinting, when compared with other tissue fabrication techniques, include, fabrication of anatomically correct shapes, fabrication of porous structures, co-culture of multiple cell types locally, controlled delivery of growth factors and genes, high-throughput tissue model generation and enabling vascularization of the tissues.

There is a huge gap between the demand and the supply of organs for transplantation. The 3D bioprinting technology has the potential to bridge this gap soon. Extensive research is underway to develop complete bio printed organs for transplantation purpose. The market for bio-printed organs will develop gradually over the coming years as the 3D bioprinting technology matures and moves out of laboratories towards commercialization. The initial success of bio printed organ transplants will likely provide the additional boost to the market in coming years.

Growing demand for organ transplantation, rise in public & private funding to support 3D bioprinting research activities, increasing usage of 3D bioprinting in drug discovery process, increasing geriatric population, and active participation of the government and the industry players in the technological advancement in the field of 3D bio printing are the factors have boosted the overall growth of this market.

Although the scientists and researchers are still working to print 3D functional human organs, 3D bioprinting already has numerous applications in toxicity testing, tissue engineering, drug discovery, consumer product testing, bone transplants, and cosmetic dentistry. Moreover, the creation of living organs and human tissue could be potentially used to replace the traditional in vivo practice been performed for the testing of drugs for various therapeutics.

However, the shortage of skilled professionals to understand the complexity of life sciences and cellular biology, the high cost of bioprinting platform and lack of regulatory guidelines governing the 3D bioprinting serve as a restraint for the growth of this market. The industry players are trying hard to get regulatory approvals for their tissue models and organs to be used directly within the human bodies.

The product segment of the market comprises of bioprinters, consumables, software, services, and others (models and molds, among others). The bioprinters acquired the highest market value in 2016, growing at the CAGR of 13.8% during the forecast period 2018-2025. However, software solutions are growing at the highest CAGR of 18.4%.

The application segment of the market comprises of research application (3D cell culture, regenerative medicine, and drug research, among others), clinical applications (dental, orthopedic, skin substitutes & grafts, and vascular tissues & organs, among others), and other applications (tools, prototypes, and molds). The research applications constituted the highest market value in 2016, growing at the CAGR of 11.9% during the forecast period 2018-2025. However, clinical application is expected to grow at the highest CAGR of 19.4% during to the forecast period 2018-2025.

The technology segment comprises of extrusion based, inkjet-based, magnetic levitation, and photocuring technology, among others. The extrusion-based technology accounted for the highest market value in 2016 which is anticipated to reach $2.59 billion by 2025. However, the magnetic levitation is expected to grow at the highest CAGR of 19.6% during the forecast period 2018-2025.

North America generated the highest market value in 2016, growing at the CAGR of 14.4%. However, Latin America, (comprising Brazil and Mexico, among others) is expected to grow at the highest CAGR of 16.8% during the forecast period 2018-2025, followed by the Asia Pacific.

Advancements in 3D bioprinting technologies coupled with the high demand for organs and tissues, government initiatives & rising investments for R&D, customization of products and competitive advantages are some of the key drivers that boost the growth of the bio-printer market globally. A wide variety of 3D bioprinters have been developed in the recent years and are still being developed from high cost to low-cost, many of them are yet to be launched in the market.

Table of Contents

Executive Summary

1 Market Overview

  • 1.1 Introduction
  • 1.2 Market Trend
  • 1.3 Historical Development in Bioprinting
  • 1.4 Comparison of Different Bioprinting Techniques for Organ Manufacturing
  • 1.5 Advancement in Bioprinting
  • 1.6 Stages of Bioprinting
    • 1.6.1 Main Steps in Organ Printing Technology

2 Market Dynamics

  • 2.1 Overview
  • 2.2 Impact Analysis of Market Drivers & Restraints
  • 2.3 Market Drivers
  • 2.4 Market Restraints
  • 2.5 Market Opportunities

3 Competitive Insights

  • 3.1 Key Development and Strategies
    • 3.1.1 New Product Launches
    • 3.1.2 Collaborations, Joint Ventures and Partnerships
    • 3.1.3 Business Expansion, Contracts & Funding
    • 3.1.4 Others
  • 3.2 Industry Attractiveness
  • 3.3 Market Share Analysis

4 Industry Analysis

  • 4.1 Patent Landscape
  • 4.2 Consortiums, Associations, and Regulatory Bodies
  • 4.3 Legal Requirements and Regulations

5 Global Bioprinting Market, by Product

  • 5.1 Overview
  • 5.2 Bioprinters
  • 5.3 Software
  • 5.4 Consumables
  • 5.5 Services
  • 5.6 Others

6 Global Bioprinting Market, by Application

  • 6.1 Overview
  • 6.2 Research Applications
    • 6.2.1 3D Cell Cultre
    • 6.2.2 Regenerative medicine
    • 6.2.3 Drug Research
    • 6.2.4 Others
  • 6.3 Clinical Applications
    • 6.3.1 Dental
    • 6.3.2 Orthpedic
    • 6.3.3 Skin Substitutes and Grafts
    • 6.3.4 Vascular Tissues and Organs
  • 6.4 Others

7 Global Bioprinting Market, by Technology

  • 7.1 Overview
  • 7.2 Inkjet Based Technology
  • 7.3 Extrusion Based Technology
  • 7.4 Magnetic Levitation
  • 7.5 Photocuring Technology
  • 7.6 Others

8 Global Bioprinting Market, by Region

  • 8.1 Overview
  • 8.2 North America
    • 8.2.1 North America by Country
    • 8.2.2 The U.S.
    • 8.2.3 Canada
  • 8.3 Europe
    • 8.3.1 Europe by Country
    • 8.3.2 Germany
    • 8.3.3 The U.K.
    • 8.3.4 France
    • 8.3.5 Italy
    • 8.3.6 Spain
    • 8.3.7 Others
  • 8.4 Asia-Pacific
    • 8.4.1 Asia-Pacific by Country
    • 8.4.2 Japan
    • 8.4.3 China
    • 8.4.4 India
    • 8.4.5 South Korea
    • 8.4.6 Australia
    • 8.4.7 Others
  • 8.5 Latin America
    • 8.5.1 Latin America by Country
    • 8.5.2 Brazil
    • 8.5.3 Mexico
    • 8.5.4 Others
  • 8.6 RoW

9 Company Profile

  • 9.1 Advanced Solutions (Life Sciences)
    • 9.1 Overview
    • 9.1.2 Product Mapping
    • 9.1.2 Corporate Summary
    • 9.1.3 Recent Developments
    • 9.1.4 SWOT Analysis
  • 9.2 Allevi (BioBots)
    • 9.2.1 Overview
    • 9.2.2 Product Mapping
    • 9.2.3 Corporate Summary
    • 9.2.4 SWOT Analysis
  • 9.3 Aspect Biosystems Ltd.
    • 9.3.1 Overview
    • 9.3.2 Product Mapping
    • 9.3.3 Corporate Summary
    • 9.3.4 SWOT Analysis
  • 9.4 Autodesk
    • 9.4.1 Overview
    • 9.4.2 Product Mapping
    • 9.4.3 Financials
    • 9.4.3.1 Financal Summary
    • 9.4.4 Recent Developments
    • 9.4.5 SWOT Analysis
  • 9.5 Cellink
    • 9.5.1 Overview
    • 9.5.2 Product Mapping
    • 9.5.3 Corporate Summary
    • 9.5.4 Recent Developments
    • 9.5.5 SWOT Analysis
  • 9.6 Digilab Inc.
    • 9.6.1 Overview
    • 9.6.2 Product Mapping
    • 9.6.3 Corporate Summary
    • 9.6.4 SWOT Analysis
  • 9.7 3Dynamics Systems Ltd.
    • 9.7.1 Overview
    • 9.7.2 Product Mapping
    • 9.7.3 Corporate Summary
    • 9.7.4 Recent Developments
    • 9.7.5 SWOT Analysis
  • 9.8 EnvisionTEC
    • 9.8.1 Overview
    • 9.8.2 Product Mapping
    • 9.8.3 Corporate Summary
    • 9.8.4 Recent Developments
    • 9.8.5 SWOT Analysis
  • 9.9 nScrypt Inc.
    • 9.9.1 Overview
    • 9.9.2 Product Mapping
    • 9.9.3 Corporate Summary
    • 9.9.4 SWOT Analysis
  • 9.10.1 Organovo Holdings, Inc.
    • 9.10.1 Overview
    • 9.10.2 Product Mapping
    • 9.10.3 Financial
    • 9.10.3.1 Financial Summary
    • 9.10.4 Recent Developments
    • 9.10.5 SWOT Analysis
  • 9.11 Poietis
    • 9.11.1 Overview
    • 9.11.2 Product Mapping
    • 9.11.3 Corporate Summary
    • 9.11.4 SWOT Analysis
  • 9.12 RegenHU Ltd.
    • 9.12.1 Overview
    • 9.12.2 Product Mapping
    • 9.12.3 Corporate Summary
    • 9.12.4 Recent Developments
    • 9.12.5 SWOT Analysis
  • 9.13 Regenovo Biotechnology Co., Ltd
    • 9.13.1 Overview
    • 9.13.2 Product Mapping
    • 9.13.3 Corporate Summary
    • 9.13.4 SWOT Analysis
  • 9.14 SunP Biotech llc
    • 9.14.1 Overview
    • 9.14.2 Product Mapping
    • 9.14.3 Corporate Summary
    • 9.14.4 SWOT Analysis
  • 9.15 Vivax Bio llc
    • 9.15.1 Overview
    • 9.15.2 Product Mapping
    • 9.15.2 Corporate Summary
    • 9.15.3 Recent Developments
    • 9.15.4 SWOT Analysis
  • 9.16 Ather
    • 9.16.1 Overview
  • 9.17 Biolife4D
    • 9.17.1 Overview
  • 9.18 Cellenion
    • 9.18.1 Overview
  • 9.19 Cyfuse Biomedical K.K.
    • 9.19.1 Overview
  • 9.20 GeSIM
    • 9.20.1 Overview
  • 9.21 Materialize NV
    • 9.21.1 Overview
  • 9.22 Regemat3D
    • 9.22.1 Overview
  • 9.23 Rokit
    • 9.23.1 Overview
  • 9.24 Sichuan Revotek Co. Ltd.
    • 9.24.1 Overview
  • 9.25 SE3D
    • 9.25.1 Overview
  • 9.26 Stratasys
    • 9.26.1 Overview

10 Annexure (Report Scope & Methodology)

List of Tables

  • 1 Comparison of Different Bioprinting Techniques for Organ Manufacturing
  • 2 New Product Launches
  • 3 Consortium, Associations & Regulatory Bodies
  • 4 Some of the Bio Printers and their Key Manufacturers
  • 5 Research Application Types Bioprinting Market, 2016-2025 ($Million)
  • 6 Clinical Application Types Bioprinting Market, 2016-2025 ($Million)
  • 7 Overview: Advanced Solutions (Life Sciences)
  • 8 Advanced Solutions (Life Sciences) Recent Developments
  • 9 Overview: Allevi
  • 10 Overview: Aspect Biosystems Ltd.
  • 11 Overview: Autodesk
  • 12 Autodesk Recent Developments
  • 13 Overview: Cellink
  • 14 Cellink Recent Developments
  • 15 Overview: 3Dynamic Systems Ltd.
  • 16 3Dynamic Systems Ltd. Recent Developments
  • 17 Overview: Digilab Inc.
  • 18 Overview: Envision TEC
  • 19 Envision TEC Recent Developments
  • 20 Overview: nScrypt Inc.
  • 21 Overview: Organovo Holdings Inc.
  • 22 Organovo Holdings Inc. Recent Developments
  • 23 Overview: Poietis
  • 24 Poietis Recent Developments
  • 25 Overview: RegenHU
  • 26 RegenHU Recent Developments
  • 27 Overview: Regenovo Biotechnology Co. Ltd.
  • 28 Overview: SunP Biotech
  • 29 Overview: Vivax Bio LLC
  • 30 Vivax Bio LLC Recent Developments
  • 31 Overview: Aether
  • 32 Overview: Biolife4D
  • 33 Overview: Cellenion
  • 34 Overview: Cyfuse Biomedical K.K.
  • 35 Overview: GeSIM
  • 36 Overview: Materialize NV
  • 37 Overview: Regemat3D
  • 38 Overview: Rokit
  • 39 Overview: Sichuan Revotek Co. Ltd.
  • 40 Overview: SE3D
  • 41 Overview: Stratasys

List of Figures

  • 1 Global Bioprinting Market: Overview
  • 2 Market Snapshot, Global Bioprinting Market, 2016
  • 3 Global Bioprinting Market Share by Product, 2016
  • 4 Global Bioprinting Market Share by Product, 2025
  • 5 Global Bioprinting Market Share by Application, 2016
  • 6 Global Bioprinting Market Share by Application, 2025
  • 7 Global Bioprinting Market Share by Technology, 2016
  • 8 Global Bioprinting Market Share by Technology, 2025
  • 9 Global Bioprinting Market Share by Region, 2016
  • 10 Global Bioprinting Market Share by Region, 2025
  • 11 Global Bioprinting Market Value by Region, 2016 -2025 ($Million)
  • 12 Global Bioprinting Market Cumulative Growth Rate (2017-2025)
  • 13 Market Segmentation
  • 14 Key Developing Trends in Bioprinting
  • 15 Stages of Bioprinting
  • 16 Market Dynamics
  • 17 Impact Analysis of Market Dynamics & Restraints
  • 18 Market Drivers
  • 19 Market Restraints
  • 20 Market Opportunities
  • 21 Share of Key Developments and Strategies
  • 22 Share of Collaborations, Partnerships & Joint Ventures
  • 23 Porter's Five Forces Analysis
  • 24 Market Share Analysis
  • 25 Patent Analysis
  • 26 Global Bioprinting Market, by Product 2016-2025 ($Million)
  • 27 Bioprinter Bioprinting Market, 2016-2025 ($Million)
  • 28 Benefits of Bioprinting
  • 29 Software Bioprinting Market, 2016-2025 ($Million)
  • 30 Consumables Bioprinting Market, 2016-2025 ($Million)
  • 31 Properties of ideal bioprinting hydrogels
  • 32 Services Bioprinting Market, 2016-2025 ($Million)
  • 33 Others Bioprinting Market, 2016-2025 ($Million)
  • 34 Global Bioprinting Market, by Application 2016-2025 ($Million)
  • 35 Research Application Bioprinting Market, 2016-2025 ($Million)
  • 36 Clinical Application Bioprinting Market, 2016-2025 ($Million)
  • 37 Others Bioprinting Market, 2016-2025 ($Million)
  • 38 Global Bioprinting Market, by Technology 2016-2025 ($Million)
  • 39 Inkjet Based Technology Bioprinting Market, 2016-2025 ($Million)
  • 40 Extrusion Based Technology Bioprinting Market, 2016-2025 ($Million)
  • 41 Magnetic Levitation Technology Bioprinting Market, 2016-2025 ($Million)
  • 42 Photocuring Technology Bioprinting Market, 2016-2025 ($Million)
  • 43 Others Technology Bioprinting Market, 2016-2025 ($Million)
  • 44 Global Bioprinting Market, by Region, 2016-2025 ($Million)
  • 45 North America Bioprinting Market, 2016-2025 ($Million)
  • 46 North America Bioprinting Market by Country, 2016-2025 ($Million)
  • 47 The U.S. Bioprinting Market, 2016-2025 ($Million)
  • 48 Canada Bioprinting Market, 2016-2025 ($Million)
  • 49 Europe Bioprinting Market, 2016-2025 ($Million)
  • 50 Europe Bioprinting Market by Country, 2016-2025 ($Million)
  • 51 Germany Bioprinting Market, 2016-2025 ($Million)
  • 52 The U.K. Bioprinting Market, 2016-2025 ($Million)
  • 53 France Bioprinting Market, 2016-2025 ($Million)
  • 54 Italy Bioprinting Market, 2016-2025 ($Million)
  • 55 Spain Bioprinting Market, 2016-2025 ($Million)
  • 56 Others Bioprinting Market, 2016-2025 ($Million)
  • 57 Market Dynamics (Europe)
  • 58 Asia-Pacific Bioprinting Market, 2016-2025 ($Million)
  • 59 Asia-Pacific Bioprinting Market by Country, 2016-2025 ($Million)
  • 60 Japan Bioprinting Market, 2016-2025 ($Million)
  • 61 China Bioprinting Market, 2016-2025 ($Million)
  • 62 China Market Dynamics
  • 63 South Korea Bioprinting Market, 2016-2025 ($Million)
  • 64 Australia Bioprinting Market, 2016-2025 ($Million)
  • 65 Others Bioprinting Market, 2016-2025 ($Million)
  • 66 Latin America Bioprinting Market, 2016-2025 ($Million)
  • 67 Latin America Bioprinting Market by Country, 2016-2025 ($Million)
  • 68 Brazil Bioprinting Market, 2016-2025 ($Million)
  • 69 Mexico Bioprinting Market, 2016-2025 ($Million)
  • 70 Others Bioprinting Market, 2016-2025 ($Million)
  • 71 RoW Bioprinting Market, 2016-2025 ($Million)
  • 72 Advanced Solutions (Life Sciences) Product Porfolio
  • 73 Advanced Solutions (Life Sciences) SWOT Analysis
  • 74 Allevi Product Portfolio-Bio Printing
  • 75 Allevi SWOT Analysis
  • 76 Aspect Biosystems Ltd. Product Portfolio-Bio Printing
  • 77 Aspect Biosystems Ltd SWOT Analysis
  • 78 Autodesk Product Portfolio-Bio Printing
  • 79 Autodesk Net Revenues, by Business Segments (2016 - 2018)
  • 80 Autodesk Net Revenues, by Business Segments (2016 - 2018)
  • 81 Autodesk Net Revenue, by Region (2016-2018)
  • 82 Autodesk SWOT Analysis
  • 83 Cellink Product Portfolio-Bio Printing
  • 84 Cellink SWOT Analysis
  • 85 Digilab Inc. Product Portfolio-Bio Printing
  • 86 Digilab Inc. SWOT Analysis
  • 87 3Dynamic Systems Ltd. Product Portfolio-Bio Printing
  • 88 3Dynamics Systems Ltd. SWOT Analysis
  • 89 Envision TEC Overall product portfolio
  • 90 Envision TEC Product Portfolio-Bio Printing
  • 91 Envision TEC SWOT Analysis
  • 92 Organovo Holdings, Inc. Product Portfolio
  • 93 Overall Financials (2015-2017)
  • 94 Organovo Holdings, Inc.. SWOT Analysis
  • 95 nScrypt Inc. Product Portfolio-Bio Printing
  • 96 nScrypt Inc. SWOT Analysis
  • 97 Poietis Product Portfolio
  • 98 Poietis Product Portfolio
  • 99 RegenHU Product Portfolio
  • 100 RegenHU Ltd. SWOT Analysis
  • 101 Regenovo Biotechnology Co. Ltd. Product Portfolio
  • 102 Regenovo Biotechnology Co.,Ltd SWOT Analysis
  • 103 SunP Biotech SWOT Analysis
  • 104 SunP Biotech SWOT Analysis
  • 105 Vivax Bio llc Product Portfolio-Bio Printing
  • 106 Vivax Bio llc. SWOT Analysis
Back to Top